Announcement
05 Dec 2017
In December 2017, the European Investment Bank (EIB) signed a loan agreement with Grifols SA to support its research and development of finding new plasma-derived protein therapies. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
05 Dec 2017
Revocation date:
No revocation date
Updated: 05 Dec 2017
State loan
In force
The EIB's loan to Grifols SA signed on 5 December 2017 was issued under the European Fund for Strategic Investment (EFSI). The loan has a total value of EUR 85 million (approx. USD 100.5 million) a...
Sign in to see more
Updated: 05 Dec 2017
State loan
In force
The loan agreement between the European Investment Bank (EIB) and Grifols SA was signed on 5 December 2017 and has a total value of EUR 85 million (approx. USD 100.5 million). The loan wi...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.